Cytel

Pharmaceutical technology and advanced analytics

Cytel is one of the leading global providers of clinical trial design SaaS software, biometric services and advanced analytics, focusing on optimising clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data.

Company Background

  • Cutting-edge clinical trial optimisation technologies that harness the full value of clinical and real-world data
  • Pioneering role in developing and delivering innovative quantitative methods to biotech and pharmaceutical companies
  • Combiation of advanced software platform and leading biometrics services offerings

Vision & Outlook

Actively support and accelerate Cytel’s next phase of growth and innovation by investing in Cytel's business and software offering

Leverage Cytel's full potential to improve speed, productivity and efficiency of clinical trials to improve human health by transforming intelligence into confident decisions

Cytel Logo Transparent

SECTOR

Technology & Payments

Healthcare

REVENUES 2021

EUR 220 million

EMPLOYEES

1,465

OWNERSHIP

Fund X

HEAD OFFICE

US

INVESTMENT DATE

2021

MANAGEMENT

Joshua Schultz

CEO

Scott Charles

CFO

RESPONSIBLE ADVISOR

Daniel Berglund

Partner